Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (1561-1570 of 3,827) with videos related to

Pageof 383
Sort By:
Cancer Cell|December 13, 2006
Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpointTiziana Bruno, Francesca De Nicola, Simona Iezzi, et al.
Cancer Cell|December 13, 2006
Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesKoei Chin, Sandy DeVries, Jane Fridlyand, et al.
Cancer Cell|January 16, 2007
Rb loss causes cancer by driving mitosis madJan M van Deursen
Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.
Cancer Cell|July 7, 2007
RXR is an essential component of the oncogenic PML/RARA complex in vivoJun Zhu, Rihab Nasr, Laurent Pérès, et al.
Cancer Cell|May 16, 2006
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in gliomaQi-Wen Fan, Zachary A Knight, David D Goldenberg, et al.
Cancer Cell|May 16, 2006
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humansDaniel R Carrasco, Tim Fenton, Kumar Sukhdeo, et al.
Cancer Cell|June 13, 2006
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancersIan J Davis, Jessica J Kim, Fatih Ozsolak, et al.
Cancer Cell|October 19, 2006
Regulation of androgen receptor activity by tyrosine phosphorylationZhiyong Guo, Bojie Dai, Tianyun Jiang, et al.
Cancer Cell|July 9, 2010
Testimony from the bedside: from Coley's toxins to targeted immunotherapyJin Mo Park, David E Fisher
Pageof 383

Showing results (1561-1570 of 3,827) with videos related to

Sort By:
Pageof 383
Cancer Cell|December 13, 2006
Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpointTiziana Bruno, Francesca De Nicola, Simona Iezzi, et al.
Cancer Cell|December 13, 2006
Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesKoei Chin, Sandy DeVries, Jane Fridlyand, et al.
Cancer Cell|January 16, 2007
Rb loss causes cancer by driving mitosis madJan M van Deursen
Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.
Cancer Cell|July 7, 2007
RXR is an essential component of the oncogenic PML/RARA complex in vivoJun Zhu, Rihab Nasr, Laurent Pérès, et al.
Cancer Cell|May 16, 2006
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in gliomaQi-Wen Fan, Zachary A Knight, David D Goldenberg, et al.
Cancer Cell|May 16, 2006
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humansDaniel R Carrasco, Tim Fenton, Kumar Sukhdeo, et al.
Cancer Cell|June 13, 2006
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancersIan J Davis, Jessica J Kim, Fatih Ozsolak, et al.
Cancer Cell|October 19, 2006
Regulation of androgen receptor activity by tyrosine phosphorylationZhiyong Guo, Bojie Dai, Tianyun Jiang, et al.
Cancer Cell|July 9, 2010
Testimony from the bedside: from Coley's toxins to targeted immunotherapyJin Mo Park, David E Fisher
Pageof 383